Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for May 2025.
-
-
Together with the Brain Health Mission, the EAN is excited to announce the launch of the Public Brain Health Day, on Monday, 23 June 2025, during the 11th EAN Congress in Helsinki. -
Brain HealthEAN News9th ESF Sleep Medicine School offers creative insights into sleep and brain health
The University of Cyprus in Nicosia was thrilled to host the highly anticipated 9th European Sleep Foundation (ESF) Sleep Medicine School from 31 March to 3 April 2025, endorsed by the EAN. -
Executive PageEAN NewsFeatured SliderExecutive Page: panels, guidelines, EBRAINS, and more ways to get involved in EAN scientific activities
EAN Scientific Committee Chair, Gereon R. Fink, provides a look at various ongoing projects, including a variety of ways you can contribute to EAN scientific activities. -
Welcome to the May 2025 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions! -
Paper of the MonthEAN NewsResearchFeatured SliderResearch Papers of the Month: Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis / Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis
Our papers of the month for May are two papers present findings from recent trials evaluating the efficacy and safety of tolebrutinib in patients with multiple sclerosis. -
AdvocacyResearch FundingEAN NewsScientific CornerTop ArticlesDraft Innovative Health Initiative (IHI) Funding Call topics related to the brain
The Innovative Health Initiative (IHI) has just published draft topic texts for its upcoming Call 11, expected to launch officially in late June 2025. -
The EAN was asked by a media outlet to provide comment on the possible role of creatine in the prevention of Alzheimer’s disease, the subject of much recent internet speculation. -
EAN NewsResearchEU Commission approves Leqembi (Lecanemab) for treatment of early-stage Alzheimer’s disease
Following an earlier decision by the EMA, the EU Commission has granted EU authorisation for Lecanemab to treat mild cognitive impairment in the early stages of Alzheimer’s disease. -
We are immensely proud to announce that the 10th Congress of the European Academy of Neurology, held at the Messukeskus, Helsinki, in 2024, has been named Best Corporate Event Subject to a Fee at the 2024 Evento Awards, a Finnish event industry award that recognises the best events, venues, speakers, creators and companies in Finland. -
Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for April 2025.
-
Executive PageAdvocacyBrain HealthEAN NewsFeatured SliderExecutive Page: If you do not communicate, you do not exist! A March full of meetings, summits and forums
EAN Communications Committee Chair, Matilde Leonardi, looks back on an extremely busy and productive period of communication activity for the EAN. -
Welcome to the April 2025 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!
-
Paper of the MonthEAN NewsResearchFeatured Slider
Research Paper of the Month: Intake of Red Meat in Relation to Dementia Risk and Cognitive Function in US Adults
Our Paper of the Month is a prospective cohort study conducted in the US, including participants from the Nurses’ Health Study (NHS) and the Health Professionals Follow-Up Study (HPFS). -
Watch a full recording of the latest European Brain Health Summit, held in Brussels on 19 March under the heading 'Brain Health for a Resilient Europe'.